GSK | The Business Standard

Photo: Collected

Coronavirus chronicle

GSK, Sanofi begin new Covid-19 vaccine trial of protein-based vaccine

The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people

Photo: Collected

Coronavirus chronicle

GSK, Vir Biotech to expand Covid -19 research partnership for other diseases

Photo: Collected

GSK says split plans on track, forecasts dip in profit this year

Representational Image. Photo: Reuters

Coronavirus chronicle

GSK, CureVac say to develop vaccine targeting Covid variants

A man rides his motorbike past a parked bus of India's biotechnology company Bharat Biotech outside its office in Hyderabad, India July 3, 2020. REUTERS/Stringer

GSK transfers malaria vaccine production to India's Bharat Biotech

Photo: Collected

Coronavirus chronicle

GSK, Vir to test antibody for Covid-19 treatment

Multinational GSK now Unilever Consumer Care

Coronavirus chronicle

GSK, Sanofi to make 200 million doses available for Covid-19 vaccine alliance

Coronavirus chronicle

GSK to widen Covid-19 antibody treatment trial after safety clearance

A booth displaying a coronavirus vaccine candidate from Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 5, 2020. Photo:Reuters

Coronavirus chronicle

Sanofi and GSK to provide 72 million vaccine doses to Canada

A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020/Reuters

Coronavirus chronicle

Sanofi, GSK launch trial for Covid-19 protein-based vaccine

Coronavirus chronicle

GSK, partner Vir join race to find Covid-19 antibody treatment

Coronavirus chronicle

Sanofi, GSK reach virus vaccine deals with US, EU